Position in TNYA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$217,811
+$110,689 QoQ
Shares Held
294,739
+90.4% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 101 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. TNYA ranks #312 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in TNYA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $217,811 | 294,739 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $107,122 | 154,801 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $48,398 | 67,977 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $368,544 | 227,497 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $171,215 | 280,223 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $120,366 | 211,171 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $437,590 | 306,008 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $609,496 | 315,802 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $681,946 | 219,983 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $429,444 | 82,112 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $241,331 | 74,485 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $302,908 | 118,788 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $441,840 | 75,271 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $63,546 | 22,297 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $82,300 | 40,946 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $114,616 | 39,523 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $108,366 | 19,248 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $320,073 | 27,171 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $271,003 | 14,301 | Shares | Defined | 2022-02-17 | |
| No filing history on record for this holder in this stock. | ||||||